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Enzymatic activity by ammonia Nessler assay, primary identification by LC-MS
methods and secondary structure characterization by FTIR techniques have
been shown in these preliminary experiments to be suitable stability-indicating
quality attributes and methods, which will be further developed.
Drug Quality & Registration (DruQuaR) format Man06.001.006-v01
Develop Nessler method for enzyme activity of ASNASE.
Characterization of primary and secondary structure of ASNASE.
DruQuaR
2.Structure characterization
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Asparaginase (ASNASE) catalyzes the deamidation of asparagine and is
therapeutically used for acute lymphoblastic leukemia (ALL)[1]. In order to
extend its clinical development, a functional-rationalized quality monograph for
ASNASE need to be established which can serve as a basis for generic
ASNASE pharmacopeial purposes or in product development and stability
studies. The quality attributes should also include the intrinsic stability and







2.1 Primary structure: LC-MS methods, e.g. whole protein mass analysis
2.3 Secondary structure: FTIR
Fig 2. The effects of the four variables and their interactions for the 
absorbance of Nessler assay following D-optimal onion experimental design 
Nessler assay 
Four variables: CKI/CHgI2, CNaOH/CHgI2, CHgI2 final and reaction time
Design of Experiment (DoE): D-optimal onion design (DOOD); The
significance of the variables and their interactions for the response
(absorbance at 425 nm) are shown at Figure 2.
Optimal ranges of four variables:
•CKI/CHgI2 [1.9-1.95]
•CNaOH/CHgI2 [17.0-18.0]
•CHgI2 final (mM) [27.0-35.0]
•Time (min) [10.0-13.0]
Fig 1. The mechanism of ASNASE activity and Nessler's reaction Secondary structure content (K2D, K2D2 and Raussens): 29.26%
α-helix and 19.68% β-sheet (mean content).
The melting temperature (Tm) : Temperature range of 60-63℃ :
denaturation of β-sheet; 63-65℃: denaturation of α-helix (Fig 4.).
Fig 3. The mass spectrum of E. coli ASNASE
Fig 5. Typical part of FTIR spectra of E. coli ASNASE: amide I and II bands 
(native ASNASE (blue) and heat-stressed ASNASE (red)
Fig 4. Temperature-stability CD spectra of E. coli ASNASE
2.2 Secondary structure: Circular dichroism (CD)
Calculated MW of E. coli ASNASE : 34590 ± 2 (Fig. 3).
Amide I and II infrared bands allow stability-indicating secondary structure
estimation.
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